Abstract:OBJECTIVE: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse drug reactions. Antiseizure medications (ASMs) with aromatic ring structure, including carbamazepine, are among the most common culprits. Screening for human leukocyte antigen (HLA) allele HLA-B*15:02 is recommended prior to initiating treatment with carbamazepine in Asians, but this allele has low positive predictive value.METHODS: We performed whole genome sequencing and analyzed 6 199 696 common variants among 113 aromatic ASM-induced SJS/TEN cases and 84 tolerant controls of Han Chinese ethnicity.RESULTS: In the primary analysis, nine variants reached genome-wide significance (p < 5e-08), one in the carbamazepine subanalysis (85 cases vs. 77 controls) and a further eight identified in HLA-B*15:02-negative subanalysis (35 cases and 53 controls). Interaction analysis between each novel variant from the primary analysis found that five increased risk irrespective of HLA-B*15:02 status or zygosity. HLA-B*15:02-positive individuals were found to have reduced risk if they also carried a chromosome 12 variant, chr12.9426934 (heterozygotes: relative risk = .71, p = .001; homozygotes: relative risk = .23, p < .001). All significant variants lie within intronic or intergenic regions with poorly understood functional consequence. In silico functional analysis of suggestive variants (p < 5e-6) identified through the primary and subanalyses (stratified by HLA-B*15:02 status and drug exposure) suggests that genetic variation within regulatory DNA may contribute to risk indirectly by disrupting the regulation of pathology-related genes. The genes implicated were specific either to the primary analysis (CD9), HLA-B*15:02 carriers (DOCK10), noncarriers (ABCA1), carbamazepine exposure (HLA-E), or phenytoin exposure (CD24).SIGNIFICANCE: We identified variants that could explain why some carriers of HLA-B*15:02 tolerate treatment, and why some noncarriers develop ASM-induced SJS/TEN. Additionally, this analysis suggests that the mixing of HLA-B*15:02 carrier status in previous studies might have masked variants contributing to susceptibility, and that inheritance of risk for ASM-induced SJS/TEN is complex, likely involving multiple risk variants.

Genetic Predictors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Aromatic Antiepileptic Drugs among the Chinese Han Population

Association Between the HLA-B*15:02 Allele and Carbamazepine-Induced Stevens-Johnson Syndrome/toxic Epidermal Necrolysis in Han Individuals of Northeastern China.

A study of HLA-B*15:02 in 9 different Chinese ethnics: Implications for carbamazepine related SJS/TEN

Strong Association Between HLA-B*1502 and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Mainland Han Chinese Patients

Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China

Hla-A*24:02 As A Common Risk Factor for Antiepileptic Drug-Induced Cutaneous Adverse Reactions

Association Study of Lamotrigine-Induced Cutaneous Adverse Reactions and HLA-B*1502 in a Han Chinese Population

Potential role of regulatory DNA variants in modifying the risk of severe cutaneous reactions induced by aromatic anti‐seizure medications

Single Nucleotide Polymorphisms of the S CN5A Gene in Han Chinese and Their Relation with Brugada Syndrome

Genetic susceptibility to the cross-reactivity of aromatic antiepileptic drugs-induced cutaneous adverse reactions.

HLA-B*13:01 as a Risk Allele for Antiepileptic Drugs-Induced Cutaneous Adverse Reactions: Higher Risk for Cross-Reactivity?

Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans

Pilot Association Study of Oxcarbazepine-Induced Mild Cutaneous Adverse Reactions with HLA-B*1502 Allele in Chinese Han Population

HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema

Phenytoin-induced Stevens–Johnson Syndrome with Negative HLA-B*1502 Allele in Mainland China: Two Cases

Unique Motif Shared by HLA-B59:01 and HLA-B55:02 is Associated with Methazolamide-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Han Chinese

The association between AED-induced cutaneous adverse drug reactions and the HLA-A, -B, and -DRB1 alleles among Caucasian patients: a pilot multicenter study

HLA-A*02 Alleles Are Associated with Tetanus Antitoxin-Induced Exanthematous Drug Eruptions in Chinese Patients.

Association Between HLA-A*3201 Allele and Oxcarbazepine-Induced Cutaneous Adverse Reactions in Eastern Han Chinese Population

The Link between HLA-B Alleles and Causative Drugs in Vietnamese Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

HLA-B*59:01: a Marker for Stevens–Johnson Syndrome/toxic Epidermal Necrolysis Caused by Methazolamide in Han Chinese